1Stevens MP,Tabrizi SN, Quirm MA,et al. Human papilomavirus genotype Prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne,Australia [J]. Int J Gynecol Cancer, 2006,16(3): 1017-1024.
2Patrieia C ,Anne R,Alex ia S,et al.Different outcome of invasive cervical cancer associated with high- risk versus intermediate- riskHPV genotype [J].International Journal of Cancer, 2009,124(4):778- 782.
3De Villiers EM,Gunst K,Stein H,et al. Esophageal squamous cell cancer in patients with head and neck cancer: prevalence of human papillomavirus DNA sequences [J]. IntJ Cancer,2004,109(2):253.
4Munoz N,Bosch Fx,Sanjose S,et al. Epidemiologie classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med, 2003,348(8) : 8.
5Andersson S,Safari H,Mints M,et al. Type distribution, viral load and integration status of high-risk human papillomaviruses in prestages of cervical cancer (CIN)[J].Br J Cancer, 2005,92(12) :2195-2200.
6Deborah S,Shirin K.Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus typesl 1 and 18.Journal of General Virology[J].2004,85 (7): 1419-1426.
7Petrie K, The Role of the Ubiquitin Ligase E6-AP in Human Papillomavirus E6-mediated Degradation of PDZ Domain-containing Protein s [J].The journal of biological chemistry, 2007, 282(3 ):65-71.
8Nakagawa S,Yano Y,Nakagawa K,et al.Analysis of the expression and locolisation of a LAP protein human scribble in the nomal and neoplastic epithelium of uterine cervix[J]. BrJ Cancer, 2004,90( 1 ) : 194-199.
9Kyung WH ,Xiaobo Z ,et al.Human Papillomavirus Type 16 E70ncoprotein Associates with the Cull-in 2 Ubiquifin Ligase Complex,Which Contributes to Degradation of the Retinoblastoma Tumor Suppressor [J].Journal of virology, 2007,81 (4):9737-9747.
10Vozenin MC, Lord HK, Hartl D, et al. Unravelling the biology of human papillomavirus (HPV) related tumours to enhance their radiosensitivity. Cancer Treat Rev, 2010 ; 36 (8) : 629 - 636.